Last year, while browsing on Aim for a target company to reverse-merge his business into, Dubliner Gerry Brandon spotted something interesting. The potential target company was called Integumen. It was a disaster of a business, with the distinction of being the worst-performing Aim flotation in 2017. By mid-2018 it was as good as dead, with a market cap of £1.2 million. Integumen listed as a loose collection of skincare products and lab science. The idea was that some of the skin products were ready for the market, others were still at R&D stage, and that somehow the thing would hang…

Special Six Nations offer

Become an annual member today for €200 and receive a free copy of ‘From Rags to Riches; The Irish Men’s Team in the Professional Era’ by Feargal O’Rourke

Subscribe

Cancel at any time.

Are you already a member? .